HK185196A - Use of interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia - Google Patents

Use of interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia

Info

Publication number
HK185196A
HK185196A HK185196A HK185196A HK185196A HK 185196 A HK185196 A HK 185196A HK 185196 A HK185196 A HK 185196A HK 185196 A HK185196 A HK 185196A HK 185196 A HK185196 A HK 185196A
Authority
HK
Hong Kong
Prior art keywords
interleukin
monocytoid
leukaemia
neutrophils
increasing numbers
Prior art date
Application number
HK185196A
Other languages
English (en)
Inventor
Eric Bonnem
Lee Sullivan
Michael Grace
Loretta Bober
John Chu-Tay Tang
David Naveh
T L Nagabhushan
Jay Raman
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK185196A publication Critical patent/HK185196A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)
HK185196A 1989-07-28 1996-10-03 Use of interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia HK185196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38693789A 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
HK185196A true HK185196A (en) 1996-10-11

Family

ID=23527716

Family Applications (1)

Application Number Title Priority Date Filing Date
HK185196A HK185196A (en) 1989-07-28 1996-10-03 Use of interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia

Country Status (20)

Country Link
EP (3) EP0618220B1 (es)
JP (2) JP2580391B2 (es)
KR (1) KR100191223B1 (es)
AT (2) ATE135366T1 (es)
AU (2) AU645514B2 (es)
CA (1) CA2064753A1 (es)
DE (2) DE69025961T2 (es)
DK (2) DK0410750T3 (es)
ES (2) ES2089875T3 (es)
FI (2) FI102039B1 (es)
GR (1) GR3019707T3 (es)
HK (1) HK185196A (es)
HU (1) HU215257B (es)
IL (2) IL95201A0 (es)
NO (1) NO304555B1 (es)
OA (1) OA09649A (es)
RU (1) RU2082756C1 (es)
SG (1) SG44544A1 (es)
WO (1) WO1991001744A2 (es)
ZA (1) ZA905896B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723119A (en) * 1989-07-28 1998-03-03 Schering Corporation Method for enhancing wound healing/repair with IL-4
US5077388A (en) * 1990-05-31 1991-12-31 Schering Corporation Purification of human interleukin-4 from a secreted escherichia coli mutant
US7449186B1 (en) * 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
AU660942B2 (en) * 1990-09-13 1995-07-13 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes
ATE135233T1 (de) * 1991-01-10 1996-03-15 Schering Corp Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren
JPH07165602A (ja) * 1993-12-16 1995-06-27 Kirin Brewery Co Ltd 放射線障害防護剤
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents
US6132737A (en) * 1997-09-29 2000-10-17 Revlon Consumer Products Corporation Method for reducing sunburn cell formation with cosmetic compositions containing ascorbic acid
EP1949910A1 (en) * 1998-11-09 2008-07-30 Biogen Idec, Inc. Treatment of chronic lymphocytic leukemia (CLL) using chimeric anti-CD20 antibody.
EP2421952B1 (en) * 2009-04-20 2016-03-30 Galen Bio, Inc. Compositions for transfection of biomolecules into cells
JP5784416B2 (ja) * 2011-08-26 2015-09-24 出光興産株式会社 菌類の回収方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4723000A (en) * 1983-07-05 1988-02-02 Biospectrum, Inc. Human interferon gamma and interleukin-2
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
US5077388A (en) * 1990-05-31 1991-12-31 Schering Corporation Purification of human interleukin-4 from a secreted escherichia coli mutant
CA2078676A1 (en) * 1990-03-21 1991-09-22 Jerome Schwartz Use of il-4 to enhance immune response to infectious antigenic challenges

Also Published As

Publication number Publication date
AU5476194A (en) 1994-06-02
KR920700670A (ko) 1992-08-10
AU661221B2 (en) 1995-07-13
EP0410750A3 (en) 1991-06-19
IL95201A0 (en) 1991-06-10
EP0410750A2 (en) 1991-01-30
DK0618220T3 (da) 1996-07-22
NO304555B1 (no) 1999-01-11
ZA905896B (en) 1991-04-24
AU645514B2 (en) 1994-01-20
DE69017547T2 (de) 1995-11-02
EP0618220B1 (en) 1996-03-13
FI102039B (fi) 1998-10-15
AU6055890A (en) 1991-03-11
HU215257B (hu) 1998-11-30
DK0410750T3 (da) 1995-07-10
JP2580391B2 (ja) 1997-02-12
DE69017547D1 (de) 1995-04-13
JPH04506299A (ja) 1992-11-05
WO1991001744A3 (en) 1991-04-04
EP0618220A1 (en) 1994-10-05
EP0484380A1 (en) 1992-05-13
FI981585A0 (fi) 1990-07-26
HU9200254D0 (en) 1992-04-28
ES2089875T3 (es) 1996-10-01
WO1991001744A2 (en) 1991-02-21
GR3019707T3 (en) 1996-07-31
IL121897A0 (en) 1998-03-10
DE69025961T2 (de) 1996-10-31
FI920367A0 (fi) 1992-01-28
NO920351D0 (no) 1992-01-27
ES2072395T3 (es) 1995-07-16
SG44544A1 (en) 1997-12-19
ATE135366T1 (de) 1996-03-15
RU2082756C1 (ru) 1997-06-27
JPH0940575A (ja) 1997-02-10
CA2064753A1 (en) 1991-01-29
KR100191223B1 (ko) 1999-06-15
HUT60146A (en) 1992-08-28
DE69025961D1 (de) 1996-04-18
ATE119395T1 (de) 1995-03-15
EP0410750B1 (en) 1995-03-08
NO920351L (no) 1992-03-27
FI981585A (fi) 1998-07-10
OA09649A (en) 1993-05-15
FI102039B1 (fi) 1998-10-15

Similar Documents

Publication Publication Date Title
DE3570046D1 (en) Process and biological contact gas scrubber for waste gas purification
HK185196A (en) Use of interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia
DE3665193D1 (en) Process and apparatus for ammonia treatment
YU50485A (en) Process for obtaining l-carnityne
GB2113667B (en) Activated-sludge process for wastewater treatment
YU43898B (en) Process for economical chrome tanning
PL299459A1 (en) Method of treating an ion exchange catalyst for use in bisphenol a synthesis processes
JPS5759519A (en) Quide tube for operating and drafting treating tool
GB2188940B (en) Chromium-free tanning process
GB2084041B (en) Process and apparatus for waste-water treatment
GR3006773T3 (es)
GB2172811B (en) Apparatus for treating sewage
FR2547294B1 (fr) Perfectionnement aux appareils de traitement des boues de stations d'epuration d'eaux residuaires
GB8514762D0 (en) Workpiece treatment & apparatus
DE3262222D1 (en) Tanning salt containing chromium (iii), and method for its manufacture
PL246880A1 (en) Apparatus for biological sewage treatment
HRP940691B1 (en) Process for economical chrome tanning
IL91346A0 (en) Process for purifying chromium-containing wastes
YU117481A (en) Process for purifying waste waters of textile, leather and similar industries
GB8808253D0 (en) Method & apparatus for improving biological reactions
PL251201A2 (en) Biological sewage treatment method
PL243415A3 (en) Process for biological sewage treatment
GB2301476A (en) Uranium treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)